Basic Information
Basic information for FAM106A-216-29aa
Peptide Name FAM106A-216-29aa
Genome Position chr17:18519495-18519581[-]
Species Human
Peptide Sequence MRVWSRVGECKSSPSTWTAVSVLSPVRKS
Peptide Length 29
Unique No (FAM106A-202-29aa,FAM106A-203-29aa,FAM106A-205-29aa,FAM106A-206-29aa,FAM106A-207-29aa,FAM106A-208-29aa,FAM106A-209-29aa,FAM106A-210-29aa,FAM106A-211-29aa,FAM106A-214-29aa,FAM106A-215-29aa,FAM106A-217-29aa,AC015818.9-201-29aa)
Grand Average of Hydropathicity -0.2138
Relative Molecular Mass 3726.21
Experimental Evidences no
lncRNA ID/Name ENSG00000273018;FAM106A
Transcript ID/Name ENST00000609832;FAM106A-216
Transcript Length 753
Coding Ability 0.3307
DNA Sequence Corresponding to Peptide ATGAGAGTGTGGAGCAGAGTTGGCGAGTGCAAGTCGAGCCCATCAACCTGGACAGCTGTCTCCGTGCTTTCACCAGTGAGGAAGAGC
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :